Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients. - Wikidata - awgldk - TriplyDB

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.

http://www.wikidata.org/entity/Q31028855

about

Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study.Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection.Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults.Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease.What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan.High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era.Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?Plasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study Evaluation of the Lipid Concentrations after Switching from Antiretroviral Drug Tenofovir Disoproxil Fumarate/Emtricitabine to Abacavir Sulfate/Lamivudine in Virologically-suppressed Human Immunodeficiency Virus-infected Patients.Association between nutritional status and the immune response in HIV + patients under HAART: protocol for a systematic review.Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.Update on tenofovir toxicity in the kidney.Ageing with HIV: a multidisciplinary review.Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV.Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients.Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study.Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study.Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women.Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo.Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India.Associations between plasma tenofovir concentration and renal function markers in HIV-infected women.

P2860

Q26995852-C3DCDF93-0370-418D-B121-3D2BBAA6656F Q28535587-6DE21D9E-E9F0-4AD9-8662-76984FAF80C6 Q28550681-72A3C80B-FC7B-4849-AB46-0393FAD12E92 Q33734997-B4745468-D927-4CFC-928C-EA8C6DD77FA0 Q34126724-89FB48D7-2147-4598-A407-CE4BB71C53BB Q34952127-EB26FC61-C002-4B79-8429-A74307769300 Q35040358-7EDFF4BC-41FA-46AB-A3A1-09E620B4A526 Q35102254-7A171D7E-7349-47DD-A49D-A1C68AC02764 Q35126728-8A37D3F8-8106-434F-9CE5-7AC29C7B9A11 Q35777009-378A94A0-F7E0-4DF1-BEBB-86C68ACDD092 Q35783289-D5FB182A-D02C-4FFC-B54A-110D79782C4A Q35852492-50C458C5-E1DF-426C-B837-CAFECA122286 Q35960625-FCCF4D36-CB3D-4890-B4B0-1E69EC74CD24 Q36113151-9BCCC12A-4309-4C26-BA8F-E576BF1B9A9E Q36576316-9B75E54A-8B6D-4410-9AC1-38270224C068 Q37278399-B8254095-D6F7-4A01-A94E-D8D34C25B536 Q37562742-51618C8A-4237-4141-84EE-69998BA95993 Q37581308-8973E924-53D8-4001-80F4-60B3186F59C1 Q37641171-3003ED7A-B56B-4957-A27C-F2019D68B58C Q37713060-1896C9A6-4659-4646-A2F4-7D1B5DCE2A6D Q38033446-79A0795D-C004-499D-A626-538D3EF0A826 Q38490362-99458A1D-8E5A-49CA-8EA1-73780DA28412 Q40219167-A6CCEA42-2F9C-471D-94B1-85D0B1770794 Q40244089-C34E9820-32F1-470F-AE02-7DC38F4D320C Q40497483-BA074A6F-62C3-479F-B909-994D4065432F Q41201528-20AB8DA9-C334-4904-8D80-520CC4FE8F9D Q41344883-7E961AF4-25E8-4BF0-8D81-047919F0C8F5 Q42279687-3A5D95C9-63AE-4CA5-BA25-77197C1D9B9B Q47151132-D9F69354-109C-4C82-BB3E-538E24F2EF43 Q52641469-80DC9339-FD77-48F1-9C46-2C1F6739F60F Q53756185-A5368D4E-2703-4A35-AA6D-07A587468992

P2860

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.

http://www.wikidata.org/entity/Q31028855

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Impact of small body weight on ...... rt study of Japanese patients.

@ast

Impact of small body weight on ...... rt study of Japanese patients.

@en

type

label

Impact of small body weight on ...... rt study of Japanese patients.

@ast

Impact of small body weight on ...... rt study of Japanese patients.

@en

prefLabel

Impact of small body weight on ...... rt study of Japanese patients.

@ast

Impact of small body weight on ...... rt study of Japanese patients.

@en

P1433

Q31028855-63AAC043-05B8-455B-91BC-66391CABEC09

P1476

Q31028855-3400255D-3CE0-4B7B-BEF9-8FA35CE695AF

P2093

Q31028855-01EB5C3E-8419-438E-B635-97440030BC91

Q31028855-1347C8BB-77C3-4C9C-A14E-28A1547E88FA

Q31028855-1386DFA4-4A80-4122-BDB8-0E4814130B37

Q31028855-2AC43D7D-DA91-4697-8A29-1F69267113ED

Q31028855-696852BA-E171-4A68-92D4-821A87B6C755

Q31028855-6F5CD468-FBB9-499D-B833-3B8B55155170

Q31028855-7C4D95B0-8E2C-4A38-8CC5-DCAFD8355A0C

Q31028855-893BFCA2-D2E8-4017-B699-5D14EA9033A1

Q31028855-AA1CAA2E-B692-4F7B-AF34-DD79BCE00FA8

Q31028855-C5A06544-A358-4A9E-B114-A74D66F6AA33

P2860

Q31028855-06A8C4C9-1C3B-4BAF-B830-A2AEBD7ACD9E

Q31028855-0BC5B464-100E-4E17-8AB8-526F7E7EAAF2

Q31028855-10773BB0-DAF9-425D-B33F-DD12AB6C5595

Q31028855-12010DE8-CBC1-4A9B-903B-61F116B33604

Q31028855-1C0B15A8-1564-42CA-AE8A-E52043DE4418

Q31028855-2465BDD9-8752-489A-97CF-7C8DB100C91F

Q31028855-2983F5FE-7D78-4F29-9B2E-363DF2CC86E2

Q31028855-39209E1C-F1AF-4ADF-A222-9DEF346E434E

Q31028855-3A3F4886-3A7D-49A5-9B34-63EA0EACAE86

Q31028855-43442748-8607-4791-87AB-D59103480352

P304

Q31028855-F7BFEDAE-AEA9-4731-9A1B-CA0BBAE1B1BB

P31

Q31028855-164405DA-5AAB-4DEA-811A-049A4842AD71

P356

Q31028855-DD8D1786-31F3-4C50-97EA-59B5D40DA433

P407

Q31028855-33F2878D-A64E-481B-A33B-168DB49F18DB

P433

Q31028855-EC4647CE-2493-4A02-8D1A-F86D36B3E270

P478

Q31028855-340E93CC-DA49-4D0D-93BF-EB5E00B59E99

P577

Q31028855-0EDCF0B2-CC1F-418B-8DAF-94EA264E00C5

P5875

Q31028855-BDDAA317-B2A4-4A02-94C4-E7440A109FEA

P698

Q31028855-E578F1AF-5FB7-47A5-B7C7-3C2737F101D8

P932

Q31028855-A030BBDF-6A3E-4ECD-876D-D1B13E0FA4A6

P356

JOURNAL.PONE.0022661

P1433

P1476

Impact of small body weight on ...... rt study of Japanese patients.

@en

P2093

Ei Kinai

http://www.w3.org/2001/XMLSchema#string

Haruhito Honda

http://www.w3.org/2001/XMLSchema#string

Hirohisa Yazaki

http://www.w3.org/2001/XMLSchema#string

Hirokazu Komatsu

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Gatanaga

http://www.w3.org/2001/XMLSchema#string

Junko Tanuma

http://www.w3.org/2001/XMLSchema#string

Katsuji Teruya

http://www.w3.org/2001/XMLSchema#string

Koji Watanabe

http://www.w3.org/2001/XMLSchema#string

Kunihisa Tsukada

http://www.w3.org/2001/XMLSchema#string

Miwako Honda

http://www.w3.org/2001/XMLSchema#string

P2860

Recent developments in HIV and the kidney

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.

Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.

Tenofovir renal toxicity targets mitochondria of renal proximal tubules.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Fluoroquinolone-induced renal failure.

P304

e22661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0022661

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51531332

http://www.w3.org/2001/XMLSchema#string

P698

21799928

http://www.w3.org/2001/XMLSchema#string

P932

3143186

http://www.w3.org/2001/XMLSchema#string